A novel ophthalmic viscosurgical device-free phakic intraocular lens implantation makes myopic surgery safer

Table 2 Preoperative patient demographics in eyes undergoing either method of phakic intraocular Lens (PIOL) implantation

Demographic	OVD-free method	Standard method	P value
Age (SD), year	28.50 (3.97)	26.81 (6.04)	0.243
Sex (%, female)	50.0%	85.7%	0.009
SE (SD), D	−13.09 (3.26)	− 13.49 (3.27)	0.676
AL (SD), mm	28.53 (1.62)	28.15 (1.73)	0.439
UDVA (IQR), logMAR	1.22 (1.02–1.40)	1.30 (1.16–1.40)	0.342
CDVA (IQR), logMAR	0.10 (0–0.15)	0.15 (0.05–0.30)	0.103
ACD (IQR), mm	3.59 (3.46–3.81)	3.73 (3.64–3.78)	0.084
CCT (IQR), μm	538.5 (518.0–564.8)	523.0 (492.5–560.0)	0.196
ECD (IQR), cells/mm²	2620.6 (2431.9–2983.9)	2620.6 (2490.7–2963.0)	0.664
IOP (IQR), mmHg	14.45 (12.65–15.95)	15.10(13.80–17.40)	0.122
PIOL Power (SD), D	−13.88 (2.78)	−14.93(2.18)	0.158

OVD = Ophthalmic Viscosurgical Device; SE = Spherical equivalent; AL = Axial length; UDVA = Uncorrected distance visual acuity; CDVA = Corrected distance visual acuity; ACD = Anterior chamber depth; CCT = Center corneal thickness; ECD = Endothelial cell density; IOP = Intraocular pressure; SD = Standard deviation; IQR = Interquartile range

ISSN: 2326-0254